1 / 6

PTCA Coronary Drug Eluting Balloons Pipeline Assessment Review 2015

The report gives thorough data on the pipeline items with near investigation of the items at different phases of improvement. The report surveys real players included in the pipeline item improvement. It additionally gives data about clinical trials in advancement, which incorporates trial stage, trial status, trial begin and end dates, and, the quantity of trials for the key PTCA Coronary Drug Eluting Balloon (DEB) pipeline items

Ctroutman01
Download Presentation

PTCA Coronary Drug Eluting Balloons Pipeline Assessment Review 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Review, 2015 By RnRMarketResearch.com Publisher Name : GlobalData Date: 07-Jul-2015 No. of pages: 48 Single User License: US $2500 Browse more Reports on Cardiovascular Device at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices/cardiovascular-device . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Review, 2015 The report gives thorough data on the pipeline items with near investigation of the items at different phases of improvement. The report surveys real players included in the pipeline item improvement. It additionally gives data about clinical trials in advancement, which incorporates trial stage, trial status, trial begin and end dates, and, the quantity of trials for the key PTCA Coronary Drug Eluting Balloon (DEB) pipeline items. This report is readied utilizing information sourced from as a part of house databases, auxiliary and essential examination by GlobalData's group of industry specialists. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Review, 2015 Companies Discussed/Mentioned in this Research: Acrostak (Schweiz) AG, B. Braun Melsungen AG, Concept Medical Inc Co., Eurocor GmbH Co., Lifetech Scientific (Shenzhen) Co., Ltd., Maxcor Inc., Micell Technologies, Inc. Co., QualiMed Innovative Medizinprodukte GmbH, The Spectranetics Corporation Co. and Vascular Nanotransfer Technologies. Explore More Research Report on Cardiovascular Device Market. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Review, 2015 Scope For PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Review, 2015 • Extensive coverage of the PTCA Coronary Drug Eluting Balloon (DEB) products under development • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities • The report reviews the major players involved in the development of PTCA Coronary Drug Eluting Balloon (DEB) products and list all their pipeline projects • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage • The report provides key clinical trial data of ongoing trials specific to pipeline products • Recent developments in the segment / industry ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Review, 2015 Reasons to Buy: • Formulate significant competitor information, analysis, and insights to improve R&D strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Identify and understand important and diverse types of PTCA Coronary Drug Eluting Balloon (DEB) products under development • Develop market-entry and market expansion strategies • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline • In-depth analysis of the product's current stage of development, territory and estimated launch date ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. PTCA Coronary Drug Eluting Balloons (DEB) - Pipeline Review, 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related